Pascale Witz

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.

Making the complex simple and the simple insightful—Philip Capsule’s Medical Device Information Platform captures and contextualizes clinical data, providing real-time patient information that can facilitate early intervention and enable better clinical outcomes. The platform simplifies three key workflow challenges: documentation, surveillance and evidence-based interventions.

Embleemas software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project ARGOS). In addition to the FDA, our platform powers the Lupus Landmark Study, the largest clinical study for lupus in the world, the Human Epilepsy Projects and tens of other clinical studies for pharmaceutical companies, biotechs and patient groups. More than half of the top 10 Investigational sites in the US use our platform: John Hopkins, NYU, UCSF, Yale, UPenn, Washington University in St Louis, Cornell and many others also such as Mayo Clinic, Yale, Georgetown.

TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to improving the oncology experience and have a passionate commitment to unconditional care, which puts science for patients first. At TESARO, we bring together working lives and human lives, inspiring future leaders, and building lasting careers. It’s a commitment we make to each member of our team. We care for you, so you can unconditionally care for people living with cancer.

At Revvity, “impossible” is inspiration, and ""cant be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is located in San Diego, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus​ scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.

The GAP Foundation is joining together leading academic researchers, pharmaceutical companies, nonprofit organizations and foundations, and governments around the world to reduce the time, cost and risk of Alzheimer’s & Parkinson's clinical trials in order to speed innovative medicines to those with or at risk of Alzheimer’s & Parkinson's disease. GAP is a standing, global, trial-ready platform to drive quality, efficiency, equity and innovation in Alzheimer’s and Parkinson's Clinical Trials, seeking to reduce clinical testing cycle times by two years or more and to achieve greater trial populations. It is doing that by building large, well-characterized trial-ready cohorts, a network of certified high-performance clinical trial sites, and an adaptive proof-of-concept trial mechanism. Connect with us on our Facebook page, @GlobalALZPlatform, and on Twitter, @GAP_Foundation, where we share updates from our GAP-Network (GAP-Net) and from the volunteers that make it all possible.

The world over, a passion for savors and specialties. Savencia is an international, independent family food group, with 25,900 employees worldwide and brands sold in 120 countries. Guided by its mission "Leading the way to better food", Groupe Savencia develops innovative and high-quality products and brands for retail, food service and industry. It relies on human-sized subsidiaries deeply rooted in their local markets, as well as on shared global expertises. Strong values, people centric approach and ambition to excellence are at the heart of the Savencia’s culture. This humanistic and entrepreneurial culture is a basis shared day by day, fostering the professional development of its employees. With its subsidiaries and stakeholders, Savencia is committed to leading the way sustainably, to encourage healthy eating and contribute to the common good, as part of its Oxygen CSR approach. The Group has two entities: Savencia Fromage & Dairy, a major player in dairy processing and N°. 5 cheese manufacturer worldwide, with a diversified brands portfolio. Iconic brands like Caprice des Dieux, Elle & Vire, St Moret, Le Rustique, St Agur, Géramont or Milkana, local leaders like Burgo de Arias, Balade, Lucina, Pribinacek, Polenghi or Ilolay, and PDO brands like Papillon, Époisses Berthaut or Lescure butter. Savencia Gourmet, an international player in chocolate and premium brands for sweet gastronomy, notably with the Valrhona, Weiss and Republica del Cacao brands, as well as La Maison du Chocolat and De Neuville stores. In France, Savencia is also present in deli and seafood with strong brands like Bordeau Chesnel, St Agaûne and Coraya. To know more about Savencia or discover our career opportunities: visit our website savencia.com

Pionnier, le Cercle InterElles est "un réseau de réseaux"​ de femmes et d’hommes engagé.e.s pour l’égalité et contre toutes les formes de stéréotypes. Il représente plus de 10 000 personnes actives au sein des 16 entreprises partenaires : CEA, Dassault Systèmes, Engie, GE, Gemalto, IBM, Intel, Lenovo, Nexter, Orange, Orano, Qualcomm, Salesforce, Schlumberger, SNCF Le Cercle InterElles se mobilise depuis bientôt 20 ans en faveur de l’égalité professionnelle dans les secteurs scientifiques et technologiques. Son ambition : encourager la mixité, promouvoir la carrière des femmes et agir auprès des pouvoirs publics afin de créer les conditions favorables à l’équilibre des genres. Il se veut avant tout un espace de questionnement et un lieu de réflexion collective. Ses membres partagent et analysent tout au long de l’année les avancées, les problématiques et les bonnes pratiques de leurs entreprises qui sont restituées lors du colloque annuel, organisé à l’occasion de la Journée Internationale des Droits des Femmes. Pour soutenir son action, le Cercle InterElles a noué des partenariats, en particulier avec l’association Femmes Ingénieurs. Il s’engage auprès de collectifs d’associations et intervient en tant que référent et expert dans le cadre de nombreux événements et dans le débat public.

INSEAD is The Business School for the World. We bring together people, cultures and ideas to develop responsible leaders who transform business and society. With locations in Europe (France), Asia (Singapore), the Middle East (Abu Dhabi), and now North America (San Francisco), INSEADs business education and research spans four regions. Our 165 renowned Faculty members from 41 countries inspire more than 1,300 degree participants annually in our MBA, Global Executive MBA, Specialised Master’s degrees (Executive Master in Finance and Executive Master in Change) and PhD programmes. In addition, more than 11,000 executives participate in INSEAD Executive Education programmes each year. INSEAD continues to conduct cutting-edge research and innovate across all our programmes. We provide business leaders with the knowledge and awareness to operate anywhere. Our core values drive academic excellence and serve the global community as The Business School for the World.

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.

Making the complex simple and the simple insightful—Philip Capsule’s Medical Device Information Platform captures and contextualizes clinical data, providing real-time patient information that can facilitate early intervention and enable better clinical outcomes. The platform simplifies three key workflow challenges: documentation, surveillance and evidence-based interventions.

Embleemas software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project ARGOS). In addition to the FDA, our platform powers the Lupus Landmark Study, the largest clinical study for lupus in the world, the Human Epilepsy Projects and tens of other clinical studies for pharmaceutical companies, biotechs and patient groups. More than half of the top 10 Investigational sites in the US use our platform: John Hopkins, NYU, UCSF, Yale, UPenn, Washington University in St Louis, Cornell and many others also such as Mayo Clinic, Yale, Georgetown.

TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to improving the oncology experience and have a passionate commitment to unconditional care, which puts science for patients first. At TESARO, we bring together working lives and human lives, inspiring future leaders, and building lasting careers. It’s a commitment we make to each member of our team. We care for you, so you can unconditionally care for people living with cancer.